查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1880491

生物活性胜肽和營養保健品市場預測至2032年：按來源、功能、形式、應用和地區分類的全球分析

Bioactive Peptides & Nutraceuticals Market Forecasts to 2032 - Global Analysis By Source (Plant-derived Proteins, Animal-derived Proteins, Marine-derived Proteins and Microbial-derived Proteins), Function, Form, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球生物活性胜肽和營養保健品市場價值將達到 718.7 億美元，到 2032 年將達到 1,391.7 億美元，在預測期內複合年成長率為 9.9%。

生物活性胜肽由短鏈胺基酸組成，除了提供基本營養外，還能帶來特定的健康益處。這些胜肽透過酵素加工、發酵和消化食物蛋白等方式產生，具有抗氧化、降血壓、抗菌和增強免疫力等特性。含有這些胜肽的營養保健品被廣泛用於維持健康和控制糖尿病、肥胖症和心臟病等慢性疾病。消費者對機能性食品和預防醫學日益成長的興趣正在推動市場成長。生物技術和胜肽萃取技術的創新拓展了這些胜肽在膳食補充劑、機能飲料和治療產品中的應用範圍，凸顯了它們在現代醫療保健和健康領域的巨大潛力。

世界衛生組織（世衛組織）指出，心血管疾病在很大程度上可以透過改變生活方式來預防，例如健康飲食、體能活動和戒菸。世衛組織也強調，將每日鹽攝取量限制在5克以下有助於降低血壓，從而降低心臟病和中風的風險。

提高消費者的健康意識

生物活性胜肽和營養保健品市場的主要驅動力是消費者對健康和預防保健日益成長的興趣。肥胖、糖尿病和心臟病等文明病的增加，促使人們尋求機能性食品和膳食補充劑。生物活性胜肽作為天然存在的蛋白質衍生物，因其安全性和有效性而優於人工合成替代品。這種轉變促使製造商開發富含胜肽的產品，包括膳食補充劑、機能飲料和強化食品，以滿足消費者日益成長的健康營養需求。消費者對更健康生活方式的偏好持續推動全球市場的擴張。

高昂的生產成本

生產成本不斷上漲是生物活性胜肽和營養保健品市場面臨的主要挑戰。高效的萃取、純化和配方製程需要對生物技術、專用酵素和精密設備進行大量投資。確保高品質的蛋白質原料並維持產品品質的穩定性進一步增加了成本。這些成本往往會推高零售價格，限制了產品在價格敏感型市場的進入。這些財務壓力使得小規模生產商難以進入市場。因此，儘管消費者需求不斷成長，但大規模生產高品質生物活性胜肽產品的經濟負擔正在阻礙市場成長。

胜肽類產品的創新

胜肽萃取、生物技術和製劑技術的進步為生物活性胜肽和營養保健品帶來了巨大的成長潛力。現代方法能夠生產出生物利用度更高、穩定性更強、且具有特異性健康功效的高品質胜肽。諸如包封、緩釋性技術以及將其添加到各種食品中等技術，能夠增強胜肽的功效並提升其對消費者的吸引力。這些創新使得開發針對特定健康需求的特效膳食補充劑、機能飲料和治療性營養保健品成為可能。利用最尖端科技，企業能夠實現產品差異化，拓展市場涵蓋範圍，並進軍新的地域市場。持續的研發投入將確保胜肽類產品在功能性營養和預防保健領域中保持領先地位。

激烈的競爭與市場飽和

生物活性胜肽和營養保健品市場面臨日益激烈的競爭和市場飽和的威脅。眾多全球及區域性生產商紛紛推出胜肽類強化產品，導致價格壓力增大，利潤空間萎縮。市場競爭激烈，產品差異化難度加大，消費者忠誠度下降。新參與企業必須投入大量資源用於行銷、創新和研發，才能有效參與競爭。市場飽和，尤其是在成熟市場，會減緩成長速度，限制商機。在激烈的競爭中，企業被迫將目光投向新興市場和細分領域，以維持市場地位並確保永續盈利。

新冠疫情的感染疾病：

新冠疫情危機對生物活性胜肽和營養保健品市場產生了重大影響。日益增強的健康意識和對增強免疫力的需求，推動了富含胜肽的膳食補充劑、機能性食品和飲料的消費量成長。具有抗氧化、抗發炎和增強免疫力功效的產品廣受歡迎。儘管供應鏈中斷和生產延誤最初阻礙了供應，但疫情加速了線上銷售和電子商務管道的發展，從而擴大了消費者覆蓋範圍。整體而言，這場健康危機凸顯了預防性營養的重要性，在推動即時需求的同時，也增強了全球生物活性胜肽和營養保健品市場的長期成長潛力。

預計在預測期內，植物來源蛋白細分市場將佔據最大的市場佔有率。

在永續性和植物性飲食需求不斷成長的推動下，預計植物來源蛋白將在預測期內佔據最大的市場佔有率。這些蛋白質來自大豆、豌豆、米和小麥，提供人體必需胺基酸，這些胺基酸可以轉化為具有多種健康益處的生物活性胜肽。由於其具有抗氧化、增強免疫力和調節血壓的特性，植物蛋白被廣泛應用於膳食補充劑、機能飲料和強化食品中。消費者對環保、符合道德標準和潔淨標示產品的日益關注，並持續推動植物來源蛋白的普及，使其成為全球膳食補充劑配方中的首選成分。

預計在預測期內，免疫調節胜肽細分市場將呈現最高的複合年成長率。

預計在預測期內，免疫調節胜肽領域將實現最高成長率，這主要得益於人們對預防保健和免疫健康的日益關注。這些胜肽能夠增強免疫反應，幫助抵抗感染疾病、發炎和壓力相關疾病。消費者對營養在免疫力中所起作用的認知不斷提高，尤其是在新冠疫情爆發之後，這促使人們更多地採用富含胜肽的膳食補充劑和機能性食品。持續的研究、新型配方以及給藥方式的創新進一步提升了這些產品的吸引力。全球健康意識的不斷增強正在推動免疫調節胜肽被添加到膳食補充劑、飲料和機能性食品中，從而推動市場強勁成長。

佔比最大的地區：

預計在預測期內，北美將保持最大的市場佔有率，這得益於其先進的醫療保健體系、消費者高度的健康意識以及對機能性食品和膳食補充劑的強烈偏好。文明病的日益增加以及對預防醫學的重視，正在推動對免疫支持和健康促進產品的需求。主要生產商的存在、先進的研發能力和嚴格的監管標準鞏固了主導地位。此外，高效的電子商務平台和完善的通路確保了消費者能夠廣泛獲取肽類膳食補充劑。這些因素共同鞏固了北美在全球生物活性胜肽和營養保健品市場的主導地位，使其成為市場收入和成長的最大區域貢獻者。

年複合成長率最高的地區：

在預測期內，亞太地區預計將實現最高的複合年成長率，這主要得益於消費者意識的提高、都市化的加快以及可支配收入的增加。預防醫學、機能性食品和免疫支持產品在注重健康的人群中越來越受歡迎。不斷拓展的數位化銷售管道、日益增強的健身意識以及大規模的人口基數正在推動對肽類膳食補充劑的需求。此外，政府的支持、研發投入的增加以及國內外企業的參與也促進了市場的擴張。這些因素共同作用，使亞太地區成為生物活性胜肽和營養保健品市場成長速度最快、成長率最高的地區。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，對主要國家的市場規模和複合年成長率進行估算和預測（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球生物活性胜肽和營養保健品市場（按成分分類）

  • 介紹
  • 植物來源蛋白質
  • 動物源性蛋白質
  • 海洋來源蛋白質
  • 微生物蛋白

6. 全球生物活性胜肽和營養保健品市場（依功能分類）

  • 介紹
  • 抗氧化胜肽
  • 抗菌胜肽
  • 抗高血壓胜肽
  • 免疫調節胜肽
  • 靶向發炎的胜肽
  • 神經支持胜肽

7. 全球生物活性胜肽和營養保健品市場（按形式分類）

  • 介紹
  • 粉末
  • 液體
  • 膠囊/片劑

8. 全球生物活性胜肽和營養保健品市場（按應用分類）

  • 介紹
  • 製藥
  • 營養補充品
  • 機能性食品和飲料
  • 化妝品和個人護理
  • 農業和飼料

9. 全球生物活性胜肽和營養保健品市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Archer Daniels Midland Company
  • Seagarden AS
  • Phermpep Co. Ltd.
  • Arlak Biotech Pvt. Ltd.
  • Naturade
  • Royal DSM
  • MYOS RENS Technology Inc.
  • Valio Oy
  • Amway
  • BASF
  • Nestle
  • Beneo
  • Nuritas
  • HELIX BIOMEDIX
  • FrieslandCampina Domo
Product Code: SMRC32526

According to Stratistics MRC, the Global Bioactive Peptides & Nutraceuticals Market is accounted for $71.87 billion in 2025 and is expected to reach $139.17 billion by 2032 growing at a CAGR of 9.9% during the forecast period. Bioactive peptides consist of short amino acid chains that provide targeted health benefits beyond basic nutrition. Produced from food proteins via enzymatic processes, fermentation, or digestion, these peptides exhibit antioxidant, antihypertensive, antimicrobial, and immune-boosting properties. Nutraceuticals, incorporating these peptides, are widely used to support health and manage chronic conditions like diabetes, obesity, and heart disease. Increasing consumer interest in functional foods and preventive health is fueling market growth. Innovations in biotechnology and peptide extraction techniques are broadening their use in supplements, functional drinks, and therapeutic products, highlighting their potential in modern healthcare and wellness applications.

According to the World Health Organization (WHO), cardiovascular diseases are largely preventable through lifestyle changes such as healthy diet, physical activity, and avoiding tobacco. WHO emphasizes that reducing salt intake to less than 5 grams per day helps lower blood pressure and reduces the risk of heart disease and stroke.

Market Dynamics:

Driver:

Rising health awareness among consumers

The bioactive peptides and nutraceuticals market is significantly propelled by heightened consumer focus on health and preventive care. Increasing incidences of lifestyle-related conditions like obesity, diabetes, and heart disease are pushing individuals toward functional foods and dietary supplements. Natural, protein-derived solutions such as bioactive peptides are preferred over artificial alternatives due to perceived safety and efficacy. This shift has encouraged manufacturers to develop peptide-fortified products, including supplements, functional drinks, and fortified foods, meeting the growing demand for wellness-focused nutrition. Consumer inclination toward healthier lifestyles continues to drive market expansion worldwide.

Restraint:

High production costs

Elevated production costs present a key challenge to the bioactive peptides and nutraceuticals market. Efficient extraction, purification, and formulation processes involve significant investment in biotechnology, specialized enzymes, and advanced equipment. Securing premium protein sources and maintaining consistent product quality further raise expenses. These costs often result in higher retail prices, restricting accessibility in cost-sensitive markets. Smaller manufacturers may face difficulties entering the sector due to these financial demands. As a result, despite increasing consumer demand, the market's growth is hindered by the economic burden of producing high-quality bioactive peptide products on a large scale.

Opportunity:

Technological innovation in peptide-based products

Technological progress in peptide extraction, biotechnology, and formulation offers significant growth potential for bioactive peptides and nutraceuticals. Modern methods produce high-quality peptides with improved bioavailability, stability, and health-specific benefits. Techniques like encapsulation, controlled release, and incorporation into diverse food products enhance effectiveness and consumer appeal. These innovations allow the creation of specialized supplements, functional drinks, and therapeutic nutraceuticals targeting particular health needs. By utilizing cutting-edge technologies, companies can differentiate products, expand market reach, and enter new regions. Ongoing research and development ensure peptide-based products remain leading solutions in functional nutrition and preventive healthcare.

Threat:

Intense competition and market saturation

The market for bioactive peptides and nutraceuticals is threatened by heightened competition and oversaturation. Many global and regional manufacturers are launching peptide-enriched products, resulting in price pressure and shrinking profit margins. A crowded marketplace can make it difficult to differentiate offerings, potentially reducing consumer loyalty. New players must allocate substantial resources to marketing, innovation, and research to compete effectively. Market saturation, especially in mature regions, may slow growth and limit revenue opportunities. Companies are compelled to focus on emerging markets or specialized niches to maintain their market position and ensure sustained profitability amid intense competition.

Covid-19 Impact:

The COVID-19 crisis had a major impact on the bioactive peptides and nutraceuticals market. Growing health awareness and the need to enhance immunity led to increased consumption of peptide-fortified supplements, functional foods, and beverages. Products offering antioxidant, anti-inflammatory, and immune-supporting benefits gained significant popularity. While supply chain interruptions and production delays initially hindered availability, the pandemic accelerated online sales and e-commerce channels, enabling broader consumer reach. Overall, the health crisis highlighted the value of preventive nutrition, resulting in immediate demand growth and reinforcing long-term expansion opportunities for the bioactive peptides and nutraceuticals market worldwide.

The plant-derived proteins segment is expected to be the largest during the forecast period

The plant-derived proteins segment is expected to account for the largest market share during the forecast period, driven by sustainability and the rising demand for plant-focused diets. Sourced from soy, peas, rice, and wheat, these proteins provide essential amino acids that can be converted into bioactive peptides offering various health benefits. They are extensively used in dietary supplements, functional beverages, and fortified foods due to their antioxidant, immune-enhancing, and blood pressure-regulating properties. Growing consumer interest in environmentally friendly, ethical, and clean-label products continues to boost the adoption of plant-derived proteins, making them the preferred choice for nutraceutical formulations worldwide.

The immune-regulating peptides segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the immune-regulating peptides segment is predicted to witness the highest growth rate due to growing attention on preventive healthcare and immune wellness. These peptides strengthen immune responses and assist the body in combating infections, inflammation, and stress-related conditions. Heightened consumer awareness of nutrition's role in immunity, particularly after the COVID-19 pandemic, has increased adoption of peptide-fortified supplements and functional foods. Ongoing research, novel formulations, and innovations in delivery methods further enhance their appeal. Rising health consciousness globally is driving the incorporation of immune-regulating peptides in dietary supplements, beverages, and functional foods, fueling strong market expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by advanced healthcare systems, high consumer health awareness, and strong preference for functional foods and supplements. The rising prevalence of lifestyle related disorders and emphasis on preventive care fuel demand for immune-supporting and wellness-focused products. The presence of key manufacturers, sophisticated research capabilities, and stringent regulatory standards enhances market leadership. Furthermore, effective e-commerce platforms and well-established distribution channels ensure broad consumer access to peptide-based nutraceuticals. These factors collectively reinforce North America's dominant position in the global bioactive peptides and nutraceuticals market, making it the largest regional contributor to market revenue and growth.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rising consumer awareness, urbanization, and increasing disposable income. Preventive healthcare, functional foods, and immunity-supporting products are gaining popularity among health-conscious populations. Expanding digital sales channels, heightened fitness awareness, and a large demographic base are driving demand for peptide-based nutraceuticals. Furthermore, government support, enhanced research and development, and the presence of both local and international companies are boosting market expansion. These factors collectively position Asia Pacific as the region with the highest growth rate, making it the fastest-growing market for bioactive peptides and nutraceutical products.

Key players in the market

Some of the key players in Bioactive Peptides & Nutraceuticals Market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Valio Oy, Amway, BASF, Nestle, Beneo, Nuritas, HELIX BIOMEDIX and FrieslandCampina Domo.

Key Developments:

In November 2025, ADM marked the start of operations for a new carbon capture and storage project at its Columbus, Nebraska Corn Processing Complex, making the complex the largest bioethanol carbon capture facility in the world. The project leverages Tallgrass's Trailblazer pipeline to transport captured carbon dioxide (CO2) from ADM's ethanol plant in Columbus to Tallgrass' Eastern Wyoming Sequestration Hub for safe, permanent storage deep underground.

In October 2025, Amway has announced plans to invest Rs 100 crore in India over the next three to five years to enhance its distribution network and expand its physical retail presence. The investment will focus on empowering its direct-selling partners and strengthening supply chain capabilities.

In June 2025, BASF has opened its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.

Sources Covered:

  • Plant-derived Proteins
  • Animal-derived Proteins
  • Marine-derived Proteins
  • Microbial-derived Proteins

Functions Covered:

  • Antioxidant Peptides
  • Antimicrobial Peptides
  • Antihypertensive Peptides
  • Immune-regulating Peptides
  • Inflammation-targeting Peptides
  • Neuro-support Peptides

Forms Covered:

  • Powder
  • Liquid
  • Capsules/Tablets

Applications Covered:

  • Pharmaceuticals
  • Nutraceuticals
  • Functional Foods & Beverages
  • Cosmetics & Personal Care
  • Agriculture & Feed

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioactive Peptides & Nutraceuticals Market, By Source

  • 5.1 Introduction
  • 5.2 Plant-derived Proteins
  • 5.3 Animal-derived Proteins
  • 5.4 Marine-derived Proteins
  • 5.5 Microbial-derived Proteins

6 Global Bioactive Peptides & Nutraceuticals Market, By Function

  • 6.1 Introduction
  • 6.2 Antioxidant Peptides
  • 6.3 Antimicrobial Peptides
  • 6.4 Antihypertensive Peptides
  • 6.5 Immune-regulating Peptides
  • 6.6 Inflammation-targeting Peptides
  • 6.7 Neuro-support Peptides

7 Global Bioactive Peptides & Nutraceuticals Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsules/Tablets

8 Global Bioactive Peptides & Nutraceuticals Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceuticals
  • 8.3 Nutraceuticals
  • 8.4 Functional Foods & Beverages
  • 8.5 Cosmetics & Personal Care
  • 8.6 Agriculture & Feed

9 Global Bioactive Peptides & Nutraceuticals Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Archer Daniels Midland Company
  • 11.2 Seagarden AS
  • 11.3 Phermpep Co. Ltd.
  • 11.4 Arlak Biotech Pvt. Ltd.
  • 11.5 Naturade
  • 11.6 Royal DSM
  • 11.7 MYOS RENS Technology Inc.
  • 11.8 Valio Oy
  • 11.9 Amway
  • 11.10 BASF
  • 11.11 Nestle
  • 11.12 Beneo
  • 11.13 Nuritas
  • 11.14 HELIX BIOMEDIX
  • 11.15 FrieslandCampina Domo

List of Tables

  • Table 1 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Source (2024-2032) ($MN)
  • Table 3 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Plant-derived Proteins (2024-2032) ($MN)
  • Table 4 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Animal-derived Proteins (2024-2032) ($MN)
  • Table 5 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Marine-derived Proteins (2024-2032) ($MN)
  • Table 6 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Microbial-derived Proteins (2024-2032) ($MN)
  • Table 7 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Function (2024-2032) ($MN)
  • Table 8 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Antioxidant Peptides (2024-2032) ($MN)
  • Table 9 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Antimicrobial Peptides (2024-2032) ($MN)
  • Table 10 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Antihypertensive Peptides (2024-2032) ($MN)
  • Table 11 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Immune-regulating Peptides (2024-2032) ($MN)
  • Table 12 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Inflammation-targeting Peptides (2024-2032) ($MN)
  • Table 13 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Neuro-support Peptides (2024-2032) ($MN)
  • Table 14 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Form (2024-2032) ($MN)
  • Table 15 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Powder (2024-2032) ($MN)
  • Table 16 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 17 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Capsules/Tablets (2024-2032) ($MN)
  • Table 18 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 20 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Nutraceuticals (2024-2032) ($MN)
  • Table 21 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Functional Foods & Beverages (2024-2032) ($MN)
  • Table 22 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Cosmetics & Personal Care (2024-2032) ($MN)
  • Table 23 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Agriculture & Feed (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.